company background image
1548 logo

Genscript Biotech SHSC:1548 Stock Report

Last Price

HK$10.66

Market Cap

HK$22.7b

7D

-2.4%

1Y

-53.0%

Updated

19 Nov, 2024

Data

Company Financials +

Genscript Biotech Corporation

SHSC:1548 Stock Report

Market Cap: HK$22.7b

1548 Stock Overview

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People’s Republic of China, Japan, the other Asia Pacific regions, and internationally. More details

1548 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Genscript Biotech Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Genscript Biotech
Historical stock prices
Current Share PriceHK$10.66
52 Week HighHK$23.60
52 Week LowHK$7.43
Beta1.05
11 Month Change-11.90%
3 Month Change-12.91%
1 Year Change-53.04%
33 Year Change-70.51%
5 Year Change-43.89%
Change since IPO-30.05%

Recent News & Updates

Recent updates

Shareholder Returns

1548HK Life SciencesHK Market
7D-2.4%-9.0%0.05%
1Y-53.0%-58.7%11.5%

Return vs Industry: 1548 exceeded the Hong Kong Life Sciences industry which returned -59.7% over the past year.

Return vs Market: 1548 underperformed the Hong Kong Market which returned 10.9% over the past year.

Price Volatility

Is 1548's price volatile compared to industry and market?
1548 volatility
1548 Average Weekly Movement9.9%
Life Sciences Industry Average Movement14.2%
Market Average Movement9.0%
10% most volatile stocks in HK Market18.9%
10% least volatile stocks in HK Market4.2%

Stable Share Price: 1548 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 1548's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20027,284Weihui Shaowww.genscript.com

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People’s Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy. The Life Science Services and Products segment provides products and services in various categories, including DNA synthesis, plasmid DNA preparation, molecular cloning, oligonucleotide synthesis, protein and antibody expression and purification, peptide synthesis, antibody development, IVT RNA production, assay cell line development and vector packing, molecular diagnostics tools, and genome editing tools and reagents, as well as instrument for protein analysis and purification, cell isolation and activation.

Genscript Biotech Corporation Fundamentals Summary

How do Genscript Biotech's earnings and revenue compare to its market cap?
1548 fundamental statistics
Market capHK$22.70b
Earnings (TTM)-HK$1.38b
Revenue (TTM)HK$7.86b

2.9x

P/S Ratio

-16.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1548 income statement (TTM)
RevenueUS$1.01b
Cost of RevenueUS$468.10m
Gross ProfitUS$541.49m
Other ExpensesUS$718.50m
Earnings-US$177.01m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.083
Gross Margin53.63%
Net Profit Margin-17.53%
Debt/Equity Ratio48.1%

How did 1548 perform over the long term?

See historical performance and comparison